Dergiler / Şişli Etfal Hastanesi Tıp Bülteni / 2019 / Cilt: 53 - Sayı: 2

Comparison of the Effects of Metoclopramide and Ondansetron on Emergency Service Observation Times in Acute Gastroenteritis-Related Nausea and Vomiting Cases

Sayfa
186–189
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, ondansetron is a more effective drug in the treatment of NV associated with acute gastroenteritis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The aim of the present study was to compare the effect of metoclopramide and ondansetron treatments on the emergency department observation time in acute gastroenteritis-related nausea and vomiting (NV).Methods: The study was conducted retrospectively on 297 patients diagnosed with acute gastroenteritis in a training and researchhospital's emergency service observation unit within 6 months.
📊
Temel Bulgular & Veri:Patients who received 4 mg ondansetronslow infusion therapy were classified as Group 1, and patients who received 10 mg metoclopramide slow infusion therapy wereclassified as Group 2.Results: The average age of the patients was 39.57±18.75 years.
💡
Sonuç & Katkı:Therefore, ondansetron is a more effective drug in the treatment of NV associated with acute gastroenteritis.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: The aim of the present study was to compare the effect of metoclopramide and ondansetron treatments on the emergency department observation time in acute gastroenteritis-related nausea and vomiting (NV).Methods: The study was conducted retrospectively on 297 patients diagnosed with acute gastroenteritis in a training and researchhospital's emergency service observation unit within 6 months. Patients with gastroenteritis who were diagnosed with NV weredivided into two groups according to the treatment they received in the observation unit. Patients who received 4 mg ondansetronslow infusion therapy were classified as Group 1, and patients who received 10 mg metoclopramide slow infusion therapy wereclassified as Group 2.Results: The average age of the patients was 39.57±18.75 years. Of the 297 participants, 56.6% (168) were female. Among them,51.5% (153) received ondansetron (Group 1), and 48.5% (144) received metoclopramide (Group 2). 6.9% weakness–numbness and4.9% akathisia were detected due to metoclopramide use. There were no adverse effects related to ondansetron use. The durationof observation ranged from 19 to 75 min in Group 1 and from 42 to 122 min in Group 2. Nineteen (13.2%) patients in Group 2 and5 (3.3%) patients in Group 1 revisited the emergency department within 24 h due to ongoing complaints.Conclusion: In conclusion, side effects of weakness and akathisia due to metoclopramide use were observed. However, no sideeffects were observed due to ondansetron use. Additionally, the use of ondansetron showed a shorter observation time and lessrecurrent admission to the emergency department. Therefore, ondansetron is a more effective drug in the treatment of NV associated with acute gastroenteritis.

🔖

Bu Makaleye Atıf Yap

AFACAN, M. A., TAYFUR, İ. (2019). Comparison of the Effects of Metoclopramide and Ondansetron on Emergency Service Observation Times in Acute Gastroenteritis-Related Nausea and Vomiting Cases. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 53 - Sayı: 2, 186–189. https://ajindex.com/articles/363996

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Eken C. Current Clinical Management Suggestions: Emergency Department Management of a Patient with Acute Diarrhea. Turk J Emerg Med 2011;1:33–9
  2. Scuderi PE. Int Anesthesiol Clin 2003;41:41–66
  3. Fujii Y, Saitoh Y, Tanaka H, Toyooka H. Anti-emetic efficacy of prophylactic granisetron, droperidol and metoclopramide in the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled trial. Eur J Anaesthesiol 1998;15:166–71
  4. Chae J, Taylor DM, Frauman AG. Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: A randomized, double-blinded, clinical trial. Emerg Med Australas 2011;23:554–61
  5. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992;77:162– 84
  6. Sandhu T, Tanvatcharaphan P, Cheunjongkolkul V. Ondansetron versus metoclopramide in prophylaxis of nausea and vomiting for laparoscopic cholecystectomy: a prospective double-blind randomized study. Asian J Surg 2008;31:50–4
  7. Bunce KT, Tyers MB. The role of 5-HT in postoperative nausea and vomiting. Br J Anaesth 1992;69:60S–2S
  8. Isal JP, Haigh CG, Hellstern K, Inall FC, Joslyn AF, Kanarek BK, et al. The clinical development of ondansetron for use in the prevention and treatment of postoperative nausea and vomiting. Eur J Anaesthesiol Suppl 1992;6:33–6
  9. Simpson K, Spencer CM, McClellan KJ. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting. Drugs 2000;59:1297–315
  10. Jokar A, Khademhosseini P, Ahmadi K, Sistani A, Amiri M, Sinaki AG. A Comparison of Metoclopramide and Ondansetron Efficacy for the Prevention of Nausea and Vomiting In Patients Suffered From Renal Colic. Open Access Maced J Med Sci 2018;6:1833–8
  11. Harmon D, Ryan M, Kelly A, Bowen M. Acupressure and prevention of nausea and vomiting during and after spinal anaesthesia for caesarean section. Br J Anaesth 2000;84:463–7
  12. Bhatia A, Tripathi KD, Sharma M. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy. Indian J Med Res 2003;118:33–41
  13. Helmy SA. Prophylactic anti-emetic efficacy of ondansetron in laparoscopic cholecystectomy under total intravenous anaesthesia. A randomised, double-blind comparison with droperidol, metoclopramide and placebo. Anaesthesia 1999;54:266–71
  14. Wu SJ, Xiong XZ, Cheng TY, Lin YX, Cheng NS. Effi